Megan C. Brown, MD, describes results from an emergency department–based initiative to improve the diagnostic accuracy of testing for von Willebrand disease in adolescents with heavy menstrual bleeding.
Recent Articles
Crizotinib Approved for Relapsed/Refractory Systemic ALCL
Crizotinib has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of children older than one year and young adults...
Daratumumab and Hyaluronidase-fihj Approved for Light Chain Amyloidosis
The combination of daratumumab and hyaluronidase-fihj and bortezomib, cyclophosphamide, and dexamethasone (D-VCd) was granted accelerated approval for the treatment of adults with newly diagnosed...
Remembering Art Nienhuis, Thomas Edgington, and more
Remembering Art Nienhuis (1941 – 2021)
Gene therapy pioneer Art Nienhuis, MD, passed away on February 3, 2021, at the age of 79.Dr. Nienhuis was...
Charting the Myeloma Immunotherapy Landscape
A bevy of forthcoming immunotherapies for multiple myeloma over the next few years raises hopes, as well as questions about combinations, sequencing, and potential...
Older Age, Pre-Existing Comorbidities Increase Poor Outcomes in Patients With SCD and COVID-19
Patients with sickle cell disease (SCD) have poor outcomes associated with COVID-19, particularly if they are older or present with end organ damage, acute...
Current Issue
March 2021 Volume 7 Issue 4
This issue examines blood services across the globe, the repercussions of increased patient access to medical information, and more.